Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,356 recalls, newest first

Class II · Moderate risk

Aripiprazole Tablets

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-279-10 D-0366-2023
Class II · Moderate risk

Aripiprazole Tablets

CGMP Deviations: recalling drug products following an FDA inspection.

Terminated cGMP deviation Accord Healthcare, Inc. NDC 16729-278-10 D-0365-2023
Class II · Moderate risk

Ohm Sanitizer Spray

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Terminated cGMP deviation Urban Electric Power D-0264-2023
Class II · Moderate risk

Ohm Hand Sanitizer

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Terminated cGMP deviation Urban Electric Power D-0263-2023
Class II · Moderate risk

Sterile Water for Injection

CGMP Deviations: potential for trace amounts of product carryover.

Terminated cGMP deviation Nephron Sc Inc NDC 0487-6105-01 D-0178-2023
Class II · Moderate risk

Menastil

cGMP Deviations

Terminated cGMP deviation Atlantic Management Resources Ltd. NDC 66233-711-01 D-0084-2023
Class II · Moderate risk

ProSirona

cGMP Deviations

Terminated cGMP deviation Atlantic Management Resources Ltd. NDC 66233-712-01 D-0083-2023
Class II · Moderate risk

Neuroquell

cGMP Deviations

Terminated cGMP deviation Atlantic Management Resources Ltd. D-0082-2023
Class II · Moderate risk

Neuroquell Plus

cGMP Deviations

Terminated cGMP deviation Atlantic Management Resources Ltd. D-0081-2023
Class III · Low risk

oxyTOCIN 30 Units/500 mL

Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).

Terminated cGMP deviation QuVa Pharma, Inc. D-1544-2022
Class II · Moderate risk

Sanitizing Hand Spray 80%

GMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Terminated cGMP deviation Salon Technologies International Inc D-0001-2023
Class II · Moderate risk

Triamcinolone Acetonide Cream USP

CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.

Terminated cGMP deviation Padagis US LLC NDC 45802-064-36 D-1497-2022

Recalls by year